Spine First Subjects Randomized in Clinical Trial Evaluating the Benefits of Total Segmental Fusion in Treating Degenerative Conditions in the Lumbar Spine byJosh SandbergMarch 19, 2026
Biologics Spine BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 30, 2022
Biologics Spine BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 22, 2022
Biologics Spine BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byJosh SandbergJune 13, 2022
Biologics Spine BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease byJosh SandbergDecember 21, 2021
COVID-19 Hospitals Regulatory This Policy Expert Explains Why The United States Will See An Increase In Non-Coronavirus Deaths (And How We Can Stop It) byJosh SandbergApril 8, 2020
COVID-19 Hospitals Regulatory Why Some COVID-19 Patients Crash: The Body’s Immune System Might Be To Blame byJosh SandbergApril 7, 2020
COVID-19 Hospitals Regulatory 8 strains of the coronavirus are circling the globe. Here’s what clues they’re giving scientists byJosh SandbergMarch 27, 2020
COVID-19 Regulatory Surgeon General has coronavirus warning: ‘This week, it’s going to get bad’ byJosh SandbergMarch 23, 2020
